Skip to Content

APO R3 (Rivastigmine Tartrate 3 mg)

Pill with imprint APO R3 is Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Apotex Corp..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO R3

Rivastigmine tartrate 3 mg APO R3
Rivastigmine tartrate 3 mg APO R3
Rivastigmine tartrate 3 mg APO R3
Rivastigmine tartrate 3 mg APO R3

Rivastigmine Tartrate

Imprint
APO R3
Strength
3 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-3221

Get help with Imprint Code FAQs.

Related Images for "APO R3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.